Cargando…

Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials

BACKGROUND: For patients with locally advanced non-small cell lung cancer (NSCLC), the standard treatment is concurrent or sequential chemotherapy with radiotherapy. Most treatment schedules use radiotherapy with conventional fractionation; however, the application of hypofractionated radiotherapy (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viani, Gustavo Arruda, Gouveia, Andre Guimaraes, Moraes, Fabio Ynoe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662485/ https://www.ncbi.nlm.nih.gov/pubmed/34992807 http://dx.doi.org/10.21037/jtd-21-573

Ejemplares similares

Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies
por: Viani, Gustavo Arruda, et al.
Publicado: (2022)

Lessons from the Brazilian radiotherapy expansion plan: A project database study
por: Hanna, Samir Abdallah, et al.
Publicado: (2022)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

Radiotherapy combined or not with chemotherapy in adult or pediatric patients with brainstem glioma: a population-based study
por: Moraes, Fabio Y., et al.
Publicado: (2023)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Hypofractionated Radiotherapy as Local Hemostatic Agent in Advanced Cancer
por: Rasool, Malik Tariq, et al.
Publicado: (2011)

Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer
por: Crane, Christopher H.
Publicado: (2016)

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
por: Iwai, Takahiro, et al.
Publicado: (2020)

Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy
por: Massaro, Maria, et al.
Publicado: (2022)

Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer
por: Spartacus, RK, et al.
Publicado: (2017)

Hypofractionated vs. standard radiotherapy for locally advanced limited-stage small cell lung cancer
por: Saeed, Nadia A., et al.
Publicado: (2022)

Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system
por: Lourenção, Marina, et al.
Publicado: (2023)

Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma
por: Shiba, Shintaro, et al.
Publicado: (2020)

Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study
por: Moraes, Fabio Y., et al.
Publicado: (2023)

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy
por: Nesseler, Jean Philippe, et al.
Publicado: (2020)

Efficacy of chemotherapy and palliative hypofractionated radiotherapy for cats with nasal lymphoma
por: NAKAZAWA, Maho, et al.
Publicado: (2021)

Assessing the efficacy of palliative radiation treatment schemes for locally advanced squamous cell carcinoma of the head and neck: a meta-analysis
por: Viani, Gustavo A., et al.
Publicado: (2023)

Practical considerations for prostate hypofractionation in the developing world
por: Yan, Michael, et al.
Publicado: (2021)

Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2021)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
por: Nguyen, Ludovic T., et al.
Publicado: (2013)

Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience
por: Das, Saikat, et al.
Publicado: (2013)

Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer
por: Bertholet, Jenny, et al.
Publicado: (2019)

Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry
por: Jamora, Kurl, et al.
Publicado: (2022)

Response to “Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?”
por: Kepka, Lucyna, et al.
Publicado: (2021)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
por: Sabbagh, Ali, et al.
Publicado: (2023)

Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
por: Viani, Gustavo Arruda, et al.
Publicado: (2021)

Palliative radiotherapy for gastric cancer: Is there a dose relationship between bleeding response and radiotherapy?
por: Viani, Gustavo Arruda, et al.
Publicado: (2020)

Concurrent Hypofractionated Radiotherapy and 5-Fluorouracil for Advanced Sarcomas of the Bone
por: Zambatis, Charalambos, et al.
Publicado: (1998)

Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer
por: Uitterhoeve, Apollonia LJ, et al.
Publicado: (2007)

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
por: Meniai-Merzouki, F., et al.
Publicado: (2018)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Cranial Spinal Spreading of Canine Brain Gliomas after Hypofractionated Volumetric-Modulated Arc Radiotherapy and Concomitant Temozolomide Chemotherapy: A Four-Case Report
por: Urso, Gaetano, et al.
Publicado: (2022)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center
por: Santos, Fred Muller dos, et al.
Publicado: (2019)

The survival benefit of intensified full-dose XELOX chemotherapy concomitant to radiotherapy and then resting-period consolidation chemotherapy in locally advanced rectal cancer
por: Zheng, Rong, et al.
Publicado: (2019)

Successful Treatment of Infantile Fibrosarcoma Spinal Metastasis by Chemotherapy and Stereotactic Hypofractionated Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2013)

Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
por: Gouveia, Andre G., et al.
Publicado: (2022)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
por: Liu, Chaoyuan, et al.
Publicado: (2023)

Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
por: Zhou, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tk16sregad0200crjg96j6qf78